KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Inventory: 2017-2025

Historic Inventory for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $90.5 million.

  • Guardant Health's Inventory rose 25.16% to $90.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.5 million, marking a year-over-year increase of 25.16%. This contributed to the annual value of $71.1 million for FY2024, which is 14.75% up from last year.
  • Per Guardant Health's latest filing, its Inventory stood at $90.5 million for Q3 2025, which was up 7.65% from $84.1 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Inventory peaked at $90.5 million during Q3 2025, and registered a low of $24.7 million during Q3 2021.
  • Over the past 3 years, Guardant Health's median Inventory value was $71.1 million (recorded in 2024), while the average stood at $70.1 million.
  • Its Inventory has fluctuated over the past 5 years, first dropped by 10.79% in 2021, then skyrocketed by 154.85% in 2022.
  • Guardant Health's Inventory (Quarterly) stood at $30.7 million in 2021, then soared by 68.21% to $51.6 million in 2022, then climbed by 20.06% to $61.9 million in 2023, then rose by 14.75% to $71.1 million in 2024, then rose by 25.16% to $90.5 million in 2025.
  • Its Inventory stands at $90.5 million for Q3 2025, versus $84.1 million for Q2 2025 and $77.3 million for Q1 2025.